OSI-211, a novel liposomal topoisomerase I inhibitor, is active in SCID mouse models of human AML and ALL

Blake Tomkinson, Ray Bendele, Francis J. Giles*, Eric Brown, Atherton Gray, Karen Hart, Jeremy D. LeRay, Denny Meyer, Michelle Pelanne, David L. Emerson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'OSI-211, a novel liposomal topoisomerase I inhibitor, is active in SCID mouse models of human AML and ALL'. Together they form a unique fingerprint.

Medicine & Life Sciences